Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58716

1.

The MHC in the Era of Next-Generation Sequencing: Implications for Bridging Structure with Function.

Petersdorf EW, O'hUigin C.

Hum Immunol. 2018 Oct 12. pii: S0198-8859(18)30912-1. doi: 10.1016/j.humimm.2018.10.002. [Epub ahead of print] Review.

PMID:
30321633
2.

Immune Reconstitution and Infection Patterns Following Early Alemtuzumab and Reduced Intensity Transplantation for Non-Malignant Disorders in Pediatric Patients.

Bhatt ST, Bednarski JJ, Berg J, Trinkaus K, Murray L, Hayashi R, Schulz G, Hente M, Grimley M, Chan KW, Kamani N, Jacobsohn D, Nieder M, Hale G, Yu L, Adams R, Dalal J, Pulsipher MA, Haut P, Chaudhury S, Davis J, Jaroscak J, Andreansky M, Willert J, Shenoy S.

Biol Blood Marrow Transplant. 2018 Oct 12. pii: S1083-8791(18)30641-4. doi: 10.1016/j.bbmt.2018.10.008. [Epub ahead of print]

PMID:
30321596
3.

During acute Graft versus Host Disease CD28 deletion in donor CD8+ , but not CD4+ , T cells maintains anti-leukemia responses in mice.

Uri A, Lühder F, Kerkau T, Beyersdorf N.

Eur J Immunol. 2018 Oct 15. doi: 10.1002/eji.201847669. [Epub ahead of print]

PMID:
30320878
4.

Extramedullary relapse of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation treated by CAR T-cell therapy: a case report.

Wang D, Shi R, Wang Q, Li J.

Onco Targets Ther. 2018 Sep 28;11:6327-6332. doi: 10.2147/OTT.S164430. eCollection 2018.

PMID:
30319272
5.

Allogeneic hematopoietic cell transplantation in chemotherapy-induced aplasia in children with high-risk acute myeloid leukemia or myelodysplasia.

Kussman A, Shyr D, Hale G, Oshrine B, Petrovic A.

Pediatr Blood Cancer. 2018 Oct 14:e27481. doi: 10.1002/pbc.27481. [Epub ahead of print]

PMID:
30318867
6.

Evaluation of cardiopulmonary exercise testing, heart function, and quality of life in children after allogenic hematopoietic stem cell transplantation.

Vandekerckhove K, De Waele K, Minne A, Coomans I, De Groote K, Panzer J, Dhooge C, Bordon V, De Wolf D, Boone J.

Pediatr Blood Cancer. 2018 Oct 14:e27499. doi: 10.1002/pbc.27499. [Epub ahead of print]

PMID:
30318730
7.

Improved accuracy of clinical HLA genotyping by next-generation DNA sequencing affects unrelated donor search results for hematopoietic stem cell transplantation.

Allen ES, Yang B, Garrett J, Ball ED, Maiers M, Morris GP.

Hum Immunol. 2018 Oct 11. pii: S0198-8859(18)30932-7. doi: 10.1016/j.humimm.2018.10.008. [Epub ahead of print]

PMID:
30316972
8.

Reduced intensity conditioning regimens, prior chronic lymphocytic leukemia, and graft versus host disease are associated with higher rates of skin cancer following allogeneic hematopoietic stem cell transplantation.

Wu PA, Stern RS, Huang V, Liu KX, Chen CA, Tzachanis D, Joyce RM, Davis RB, Ho VT.

J Invest Dermatol. 2018 Oct 11. pii: S0022-202X(18)32659-9. doi: 10.1016/j.jid.2018.08.025. [Epub ahead of print] No abstract available.

PMID:
30316899
9.

Cryptococcal meningitis following umbilical cord blood transplantation, association between the occurrence of cryptococcal infection and tacrolimus discontinuation among allogeneic hematopoietic stem cell recipients.

Mitsuki T, Kimura M, Araoka H, Kageyama K, Takagi S, Yamamoto G, Nakamura S, Miyazaki Y, Uchida N, Yoneyama A, Taniguchi S.

J Infect Chemother. 2018 Oct 10. pii: S1341-321X(18)30317-9. doi: 10.1016/j.jiac.2018.09.006. [Epub ahead of print]

PMID:
30316744
10.

The Impact of Body Mass Index on the Outcome of Hematopoietic Stem Cell Transplantation in Adults.

Doney K, McMillen K, Buono L, Deeg HJ, Gooley T.

Biol Blood Marrow Transplant. 2018 Oct 10. pii: S1083-8791(18)30615-3. doi: 10.1016/j.bbmt.2018.10.006. [Epub ahead of print]

PMID:
30315943
11.

Extended CCR5 Blockade for Graft-Versus-Host Disease Prophylaxis Improves Outcomes of Reduced Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.

Reshef R, Ganetsky A, Acosta EP, Blauser R, Crisalli L, McGraw J, Frey NV, Hexner EO, Hoxie JA, Loren AW, Luger SM, Mangan J, Stadtmauer EA, Mick R, Vonderheide RH, Porter DL.

Biol Blood Marrow Transplant. 2018 Oct 10. pii: S1083-8791(18)30601-3. doi: 10.1016/j.bbmt.2018.09.034. [Epub ahead of print]

PMID:
30315941
12.

Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.

Denzen EM, Preussler JM, Murphy EA, Baker KS, Burns LJ, Foster J, Idossa L, Moore HK, Payton TJ, Haven D, Jahagirdar B, Kamani N, Rizzo JD, Salazar L, Schatz BA, Syrjala KL, Wingard JR, Majhail NS.

Biol Blood Marrow Transplant. 2018 Oct 10. pii: S1083-8791(18)30614-1. doi: 10.1016/j.bbmt.2018.10.005. [Epub ahead of print]

PMID:
30315940
13.

Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore.

Hoay KY, Ratnagopal P.

Acta Neurol Taiwan. 2018 Mar 15;27(1):26-32. No abstract available.

PMID:
30315559
14.

Peripheral stem cell apheresis is feasible post 131Iodine-metaiodobenzylguanidine- therapy in high-risk neuroblastoma, but results in delayed platelet reconstitution.

Kraal KC, Timmerman I, Kansen HM, van den Bos C, Zsiros J, van den Berg H, Somers SF, Braakman E, Peek AML, van Noesel M, van der Schoot CE, Fiocco M, Caron HN, Voermans C, Tytgat GAM.

Clin Cancer Res. 2018 Oct 12. pii: clincanres.1904.2018. doi: 10.1158/1078-0432.CCR-18-1904. [Epub ahead of print]

PMID:
30314967
15.

Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.

Zeidan AM, Shallis RM, Wang R, Davidoff A, Ma X.

Blood Rev. 2018 Sep 21. pii: S0268-960X(18)30065-1. doi: 10.1016/j.blre.2018.09.001. [Epub ahead of print] Review.

PMID:
30314642
16.

CD3+/CD19+ depleted matched and mismatched unrelated donor hematopoietic stem cell transplant with targeted T cell addback is associated with excellent outcomes in pediatric patients with non-malignant hematologic disorders.

Oved JH, Wang Y, Barrett DM, Levy EM, Huang Y, Monos DS, Grupp SA, Bunin NJ, Olson TS.

Biol Blood Marrow Transplant. 2018 Oct 9. pii: S1083-8791(18)30612-8. doi: 10.1016/j.bbmt.2018.10.003. [Epub ahead of print]

PMID:
30312755
17.

Porcine signal regulatory protein alpha binds to human CD47 to inhibit phagocytosis: Implications for human hematopoietic stem cell transplantation into severe combined immunodeficient pigs.

Boettcher AN, Cunnick JE, Powell EJ, Egner TK, Charley SE, Loving CL, Tuggle CK.

Xenotransplantation. 2018 Oct 12:e12466. doi: 10.1111/xen.12466. [Epub ahead of print]

PMID:
30311702
18.

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma.

Greenbaum AM, Green DJ, Holmberg LA, Gooley T, Till BG, Budde LE, Rasmussen H, Press OW, Gopal AK.

Blood Res. 2018 Sep;53(3):223-226. doi: 10.5045/br.2018.53.3.223. Epub 2018 Sep 28.

19.

Cerebral Blood Flow and Marrow Diffusion Alterations in Children with Sickle Cell Anemia after Bone Marrow Transplantation and Transfusion.

Whitehead MT, Smitthimedhin A, Webb J, Mahdi ES, Khademian ZP, Carpenter JL, Abraham A.

AJNR Am J Neuroradiol. 2018 Oct 11. doi: 10.3174/ajnr.A5830. [Epub ahead of print]

PMID:
30309846
20.

Graft-versus-host disease.

Moreno DF, Cid J.

Med Clin (Barc). 2018 Oct 8. pii: S0025-7753(18)30518-9. doi: 10.1016/j.medcli.2018.07.012. [Epub ahead of print] Review. English, Spanish.

PMID:
30309668

Supplemental Content

Loading ...
Support Center